Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Blood soluble OX40 (CD134) levels in advanced colorectal cancer

Products are for professional/laboratory use only.

A recent publication in the oncology field revealed that high blood levels of soluble OX40 indicate reduced survival in patients with advanced colorectal cancer (CRC).

The study published in Oncology Reports utilised the IBL Human CD134/OX40 ELISA Assay in the investigation of 22 patients with advanced CRC.

Learn more about the article

Click Here >

Ordering information:

Product Code: IB30168993

Description: CD135/OX40 ELISA


Find out more about the ELISA assay

View assay details >

Contact us for a quote

Contact Us Now >



Request a Quote

Request Quote

Recent Posts

Epredia – Laser Cassettes

Designed to achieve optimal performance with Vega and Nova laser cassette printers.Printing Specialty laser cassettes are engineered to ensure 600 dpi print quality when used…

Read full article

Milestone – Is your grossing station compliant?

Formaldehyde Under Control With formaldehyde now firmly being in focus under Safe Work Australia, WorkSafe NZ, and accreditation expectations such as NATA, laboratories are being…

Read full article

HistoCyte™ – The Issue with Tissue

Laboratories are dependent on using the tissue that they produce as the control for subsequent tests performed. Tissues, or more specifically the biomarkers of interest,…

Read full article